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Background: Volume targeting by bi-level positive pressure ventilation (BPPV) has recently
been made available by several manufacturers for home care ventilators. Although it may im-
prove nocturnal ventilation, we hypothesized that increased pressure swings related to volume
targeting may have a deleterious effect on sleep structure and patient comfort.
Methods: Patients in stable clinical condition (nZ 12) treated by BPPV for obesity-
hypoventilation (BMI: 44 8 kg/m2) for a median of 30 months (range: 2e138), underwent noc-
turnal polysomnography with transcutaneous capnography on 2 consecutive nights with either
BPPV and usual ventilator settings or BPPV with volume targeting, in randomized sequence.
Subjective quality of sleep (St. Mary’s Hospital Questionnaire) and comfort of ventilation
(VAS scales) were also assessed.
Results: Mean IPAP, mean tidal volume, and total ventilation increased significantly with vol-
ume targeting. Control of nocturnal hypoventilation was slightly improved with volume target-
ing (nocturnal TcPCO2: 42 9 vs. 45 5 mm Hg, pZ 0.04). However, total sleep time and stage
2 sleep were greater without volume targeting, and wake after sleep onset and awakenings
>20 s increased with volume targeting. Subjectively, patients described a lighter sleep, ofses; AVAPS, Average volume-assured pressure support; BMI, Body-mass index; BPPV, Bi-level positive
positive airway pressure; EPAP, Expiratory positive airway pressure; MAI, Micro-arousal index; NREM,
, Non-invasive positive pressure ventilation; OHS, Obesity-hypoventilation syndrome; ODI, Oxygen
aphy; REM, Rapid eye movement sleep; SpO2, Oxygen saturation; SDB, Sleep-disordered breathing;
2, Transcutaneous carbon dioxide partial pressure; VT, Tidal volume; WASO, Wake after sleep onset.
formed: Sleep Laboratory, Department of Psychiatry, Geneva University Hospital, Switzerland.
inicaltrials.gov (Title: Efficacy of average volume-assured pressure support with bi-level pressure sup-
NCT00479284).
tuberculeux, Service de Pneumologie, Hoˆpital Cantonal Universitaire, 25 rue Micheli-du-Crest, 1211
372 95 46; fax: þ41 22 372 99 29.
sens@hcuge.ch (J.-P. Janssens), marie.metzger@hcuge.ch (M. Metzger), esforza@chu-reims.fr
8 Elsevier Ltd. All rights reserved.
166 J.-P. Janssens et al.lesser quality and more frequent awakenings with volume targeting; ventilation was perceived
as less comfortable, with an increased perception of leaks and of ‘‘too much air’’.
Conclusion: In stable patients treated by BPPV for obesity-hypoventilation, volume targeting
improved control of nocturnal hypoventilation at the expense of a slight decrease in objective
and subjective sleep quality, and comfort of ventilation.
ª 2008 Elsevier Ltd. All rights reserved.Refused to participate
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Figure 1 Flow chart of patient selection. Patients were se-
lected among all subjects with chronic respiratory failure due
to obesity-hypoventilation, treated for at least 2 months by
BPPV with a Synchrony ventilator (Respironics, USA: the
only bi-level ventilator with a volume targeting option avail-
able at time of study in our area).Introduction
Bi-level positive pressure ventilators, introduced in the late
1980s,1 have become by far the most widely used ventila-
tors in most situations of chronic hypercapnic respiratory
failure2,3 such as COPD or obesity-hypoventilation.2 There
are, however, considerable variations in performances of
available bi-level positive pressure ventilators4; further-
more, one limitation of bi-level pressure support ventila-
tion (BPPV) is the absence of guarantee as to volume
delivered to the patient. Volume targeting is a feature re-
cently made available on certain bi-level ventilators (i.e.,
Synchrony, Respironics Inc., Murrysville, PA; VENTIIogic,
VENTImotion, Weinmann, Hamburg, Germany; VS Ultra
and EliseeTM 150, ResMed, Sydney, Australia; Legendair
and Smartair, Covidien AG, Bermuda) which aims to solve
this limitation: the ventilator measures or estimates
delivered tidal volume (VT) through a built-in pneumota-
chograph and adjusts pressure support within a preset
range to provide a VT as close as possible to a target VT
set by the clinician.
A recent clinical trial showed that volume targeting
(average volume-assured pressure support: AVAPS, Res-
pironics Inc., Murrysville) improved control of nocturnal
hypoventilation when compared to conventional BPPV.5
However, we know that patients on non-invasive positive
pressure ventilation (NPPV) have impaired sleep quality
and increased sleep fragmentation, as a result of leaks,6
glottic closure, central apnea or hypopnea,7e9 or patient-
ventilator asynchrony.10,11 Since, during BPPV with volume
targeting, substantial variations in pressure levels are possi-
ble, and maximal inspiratory positive airway pressure (IPAP)
values are higher than with usual settings, one could expect
reduced patient comfort and a deleterious impact of volume
targeting on sleep quality. The aim of the current study was
to assess correction of nocturnal hypoventilation, as well as
quantity and quality of sleep during BPPV with and without
volume (VT) targeting in patients with obesity-hypoventila-
tion syndrome already familiar with BPPV. We hypothesized
that BPPV with VT targeting would be associated with greater
sleep fragmentation and impaired subjective sleep quality.
Patients and methods
Study population
Twelve outpatients with OHS (defined as BMI 30 kg/m2 and
diurnal PaCO2 45 mm Hg), and treated with NPPV by the
Division of Pulmonary Diseases of Geneva University Hospi-
tal were prospectively recruited between June 1, 2006 and
March 30, 2007 (see Fig. 1 for patient selection). Inclusioncriteria were: (1) stable clinical condition; (2) home treat-
ment with a Synchrony bi-level pressure support respirator
(Respironics Inc, Murrysville, PA) for obesity-hypoventila-
tion syndrome for at least 2 months; and (3) NPPV initiated
after at least one episode of acute hypercapnic respiratory
failure. Exclusion criteria were: any unstable cardiac or re-
spiratory condition, and/or poor compliance defined by
a daily use of ventilator of less than 4 h.
The study protocol was approved by the Ethics Commit-
tee for Medical Research of Geneva University Hospital and
written informed consent was obtained from all partici-
pants. The trial was registered at www.clinicaltrials.gov
(Identifier: NCT00479284).
Study design
Patients were randomized to receive either BPPV with usual
ventilator settings or with VT targeting (average volume-
assured pressure support: AVAPS) on the first night and
then crossed over to the alternate ventilatory modality on
the second night. Nocturnal polysomnography was per-
formed in the Sleep Laboratory of Geneva University Hospi-
tal and associated with transcutaneous capnography.
AVAPS requires determining a target tidal volume (VT),
and a range of IPAP values allowing the ventilator to adapt
pressure support to delivered volume (estimated by a built-
in pneumotachograph in the ventilator). Target volume
recommended by the manufacturer in obese patients is
Impact of average volume-assured pressure support on non-invasive ventilation 1677e8 ml/kg (or 8e12 ml/kg of ideal body weight). Maximal
IPAP was initially set at 30 cm H2O, and then adjusted ac-
cording to tolerance and leaks, during a daytime 30 min
trial. Minimal IPAP value was set at usual IPAP level minus
3 cm H2O. Settings for EPAP, back-up respiratory rate, and
inspiratory/expiratory ratio were not modified. Default in-
terface was a full face mask, or, when not tolerated, a nasal
mask. Whenever oxygen was required, oxygen flow was
identical for both measurements.
Nocturnal recording
Standard polysomnographic recording (PSG) was performed
(Brainlab, Schwartzer, Germany) using seven electroen-
cephalograms (EEG), right and left electrooculograms and
one electromyogram of chin muscle for conventional sleep
staging. Respiratory airflow was monitored with a nasal
cannula connected to a pressure transducer (Protech 2,
Minneapolis, MN, USA); thoracic and abdominal respiratory
movements were monitored with piezoelectric strain
gauges, and tracheal sound: by microphone. Arterial
oxygen saturation (SpO2) was continuously measured with
a pulse oximeter and a finger probe. Minimal and mean
SpO2, percentage of total sleep time with SpO2 <88%, and
oxygen desaturation index (ODI) (transient desaturation de-
fined as a decrease in SpO2 of 3%) were recorded. Positive
pressure level was continuously measured at the mask and
recorded during the nocturnal study.
Transcutaneous measurements of carbon dioxide
(TcPCO2) were performed using a Radiometer Tina TCM4
capnograph (Radiometer, Copenhagen, Denmark). Cali-
bration of the electrode was performed before each new
measurement, with a standard (5% CO2, 20.9% O2) calibra-
tion gas. To ensure optimal performance, the membrane
of the electrode was changed for each recording.12 The
electrode was positioned on the anterior chest wall. The
temperature of the electrode was set at 43 C. Mean, me-
dian, maximal, and minimal TcPCO2 values were recorded.
Sleep parameters
Sleep was scored according to the standard criteria using 20-s
epochs.13 The investigator scoring the sleep study (ES) was
blinded to the ventilator settings and subjective evaluation.
The following sleep parameters were quantified: total sleep
time (TST), sleep efficiency (SE: TST/total recording
time 100), percentage of each sleep stage, wake after sleep
onset (WASO) and sleep latency. As indices of sleep fragmen-
tation, we considered the number of awakenings (lasting
>20 s and>2 min), sleep stage shifts, the sleep fragmentation
index (SFI) (defined as number of awakenings lasting  20 s
plus sleep stage shifts/total sleep time, per hour),14 and the
index of micro-arousals (MAI). MAI were defined according to
ASDA criteria as a return to alpha or fast frequency, well differ-
entiated from the background EEG activity15 lasting >1.5 s.16
Subjective evaluation of quality of sleep and
comfort of ventilation
The St. Mary’s Hospital Questionnaire,17 a self-report ques-
tionnaire designed to assess sleep quality as well as sleeplatency and sleep length, was used to evaluate subjective
sleep quality during the 2 nights spent in the laboratory.
To evaluate comfort, perception of patient-ventilator
synchronisation, airflow, leaks, and noise of ventilator, an
eight-item visual analogic scale was administered in the
morning following the sleep study. Higher values indicate
better treatment comfort.
Statistical analysis
Results in text and tables are presented as mean SD,
unless specified otherwise. Comparison between both re-
cordings was performed using paired Student’s t test for
continuous variables and Wilcoxons’ signed rank test for
non-parametric variables. Level of significance was set at
p 0.05 for all tests. All statistical analyses were
performed with Statview software Version 5.0 for PC com-
puters (SAS Institute Inc., Cary, North Carolina).
Results
Among all patients followed by the Division of Pulmonary
Diseases of Geneva University Hospital, treated by NPPV for
OHS with a Synchrony ventilator (Fig. 1), 12 patients (eight
males, four females, aged 59.6 10.4 years), all severely
obese (body-mass index: 43.9 8.3 kg/m2) fulfilled inclu-
sion criteria and were included. Pulmonary function tests
were (% predicted, mean SD): FEV1: 80 36; FVC:
87 26; FEV1/FVC: 91 14; maximal mouth inspiratory
pressure: 86 31. Arterial blood gases, recorded in a stable
condition without NPPV for at least 1 h, were (room air,
mm Hg, mean SD): PaO2: 68 13; PaCO2: 44 11; pH:
7.42 0.03; SaO2 (%): 94 3.
Patients had been under NPPV for (median, range): 30
(2e138) months, with an average use of their ventilator
over the previous 30 days e determined by built-in counter
e of (hh:mm/day SD): 6:33 2:11. Initiation of home
NPPV was elective in two cases and followed acute hyper-
capnic respiratory failure in 10 cases. All ventilators
(Synchrony, Respironics Inc., Murrysville, PA) were in S/T
mode (Spontaneous/Timed), a mode which allows trigger-
ing of the ventilator by the patient while assuring a security
back-up rate. As previously described,2 adjustment of ven-
tilator settings and oxygen supplementation aimed to
obtain the lowest possible value for daytime PaCO2 (or noc-
turnal TcPCO2) with the ventilator, and a mean nocturnal
SpO2 <88%, with <20% of the nocturnal total recording
time having <88% of SpO2. Expiratory positive airway pres-
sure values were titrated to minimize the desaturation
index under BPPV. Nine patients had full face masks and
three had nasal masks. Three patients had supplemental
oxygen.
Table 1 shows ventilator settings with and without VT
targeting, which was adjusted according to manufacturer’s
recommendations. Fig. 2 summarizes data downloaded
from ventilator (Encore Pro Software, Respironics, USA)
recorded from the built-in pneumotachograph: as ex-
pected, mean IPAP was significantly higher with VT target-
ing (24.3 3.3 vs. 21.7 4.7 cm H2O; pZ 0.003), as well
as mean tidal volume (VT: 764 139 vs. 670 177 ml;
pZ 0.003), and total ventilation (VE: 10.8 2.8 vs.
Table 1 Ventilators settings with and without VT targeting and estimated VT.
Baseline ventilator settings Ventilator settings with VT targeting
Patient
number
IPAP
(cm H2O)
EPAP
(cm H2O)
Respiratory
back-up (rate/min)
IPAP min
(cm H2O)
IPAP max
(cm H2O)
Targeted
VT (ml)
Targeted
VT (ml/kg)
Estimated
VT (ml)
Estimated
VT (ml/kg)
1 22 6 15 19 30 900 7.8 714 6.2
2 18 6 12 15 25 500 8.5 464 7.9
3 28 5 17 24 30 825 7.5 678 6.2
4 24 8 12 21 30 1000 7.1 790 5.6
5 19 14 12 18 24 1000 7.1 744 5.3
6 14 8 14 15 21 1000 7.4 693 5.1
7 26 12 12 23 30 900 8.2 898 8.2
8 28 8 10 25 30 975 8.1 808 6.7
9 26 12 14 23 29 1000 5.7 969 5.5
10 18 8 15 15 25 850 7.0 774 6.3
11 18 8 15 8 25 1200 8.1 964 6.5
12 18 8 12 15 25 800 7.9 680 6.7
Mean 21.6 8.6 13.3 18.4 27.0 912.5 7.5 765 6.4
SD 4.7 2.7 2.0 5.0 3.2 168.4 0.8 140 0.9
VT: tidal volume, ml; IPAP: inspiratory positive airway pressure, cm H2O; EPAP: expiratory positive airway pressure, cm H2O; EPAP and
back-up respiratory rate settings were not modified. Subjects 3, 7 and 8 had supplemental O2.
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Figure 2 Parameters downloaded from ventilator (Encore Pro Software, Respironics, USA) recorded during nights under bi-level
positive pressure ventilation (BPPV) with and without VT targeting. A: mean values for inspiratory positive airway pressure (IPAP,
cm H2O); B: average tidal volume (VT, ml); C: average maximal flow rate (L/min); D: average ventilation (L/min). p Values for
paired Student t test.
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Impact of average volume-assured pressure support on non-invasive ventilation 1699.5 2.8 L; pZ 0.02). Effective VT did not reach, however,
targeted VT (Table 1). Respiratory rate (pZ 0.28) and aver-
age maximal inspiratory flow (pZ 0.1) were unchanged.
Transcutaneous capnography and pulse oximetry
Results are shown in Fig. 3. Mean TcPCO2 was significantly
reduced with VT targeting (45.5 5.1 vs. 42.4
9.0 mm Hg; pZ 0.04). There was a small but significant in-
crease in the time spent with an SaO2 <88% with VT target-
ing, although mean, minimal SaO2, and oxygen desaturation
index (n/hour; 10 10 with VT targeting vs. 11 12;
pZ 0.4) did not differ between both ventilation modes.
Only one case (N7) increased nocturnal TcPCO2 (and
time spent with SaO2 <88%) with VT targeting: this case
had severe OHS with OSAS, had persistent nocturnal
hypoventilation in spite of BPPV and did not tolerate
higher IPAP pressures. Deleting this case increased the84
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Figure 3 Results of pulse oximetry and transcutaneous capnogra
tilation (BPPV) with and without VT targeting. A: mean oxygen satu
cording time); C: minimal SaO2 value (%); D: mean transcutaneous
Only one subject increased time spent with SaO2 <88% and TcPCOimpact of VT targeting on mean TcPCO2 (40.3 4.2 mm Hg
vs. 44.3 3.5; pZ 0.003).
Polysomnographic data and subjective assessment
of quality of sleep
Objectively, patients slept better without VT targeting: to-
tal sleep time and stage 2 sleep were greater, and WASO
shorter (Table 2). Despite the fact that MAI and SFI were un-
affected by the change in ventilation mode, the number of
awakenings >20 s was lower without VT targeting. However,
no significant differences in the amount of slow wave sleep
or REM sleep was found between the two modes of
ventilation.
Subjectively, patients rated their sleep quality and
continuity as worse with VT targeting (Table 3): their sleep
was perceived as lighter, and they reported more awaken-
ings. No significant differences were reported in subjective0%
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phy recorded during night under bi-level positive pressure ven-
ration (SaO2, %); B: time spent with SaO2 <88% (% of total re-
CO2 value (TcPCO2, mm Hg). p Values for paired Student t test.
2 with VT targeting.
Table 2 Polysomnographic data with and without VT
targeting.
Without VT
targeting
mean SD
With VT
targeting
mean SD
p Value
TST (min) 397 79 334 68 0.004
Sleep efficiency (%) 75 10 68 11 0.06
Sleep latency (min) 14 12 21 19 0.1
Stage 1 (% of TST) 22.6 6.4 25.7 8.7 0.07
Stage 2 (% of TST) 55.6 6.9 50.4 6.3 0.007
Slow wave sleep
(% of TST)
8.8 5.3 10.6 5.6 0.11
REM sleep
(% of TST)
13.8 5.4 13.2 5.8 0.28
Stage changes (n) 394 145 326 98 0.019
Wake after sleep
onset (% of TST)
25.8 10.6 33.8 12.0 0.017
Awakenings
>2 min (n)
101 38 97 29 0.31
Awakenings >20 s (n) 11 7 16 8 0.05
Micro-arousal
index (n/h)
32 11 30 12 0.22
Sleep fragmentation
index (n/h)
75 27 78 30 0.27
TST: total sleep time; REM: rapid eye movement sleep; p value
for paired Student’s t test.
170 J.-P. Janssens et al.sleep latency, morning sleep latency, and sleep satisfaction
between ventilation modes.
Comfort of ventilation
Patients complained of an overall less comfortable ventila-
tion with VT targeting, with a more frequent perception of
‘‘too much air delivered’’, and increased leaks, leading to
worse sleep quality (Table 3). Leaks could not be objectively
assessed with the built-in software of the Synchrony ventila-
tors used, although more recent models offer this feature.
Discussion
In this study, our aim was to determine, in stable patients
treated by BPPV for OHS and thus accustomed to BPPV,
whether VT targeting provided an additional benefit over
standard BPPV in terms of efficacy of ventilation, and if
so, at what cost in terms of sleep structure and comfort.
VT targeting significantly improved control of nocturnal
TcPCO2, and increased average nocturnal VT and VE. How-
ever, polysomnographic studies showed that, with VT tar-
geting, TST and stage 2 sleep were significantly lower,
and wake after sleep onset (WASO) was increased. Although
indexes of sleep fragmentation (MAI and SFI) were unaf-
fected by VT targeting, awakenings >20 s were more fre-
quent. Subjectively patients described BPPV with VT
targeting as less comfortable, with a more frequent percep-
tion of receiving too much air, and an increased perception
of leaks.
To date, only two clinical studies have analysed the
possible contribution of VT targeting in NPPV.
5,18 The firstwas a short (2 h) single-blinded cross-over study, in 10 sta-
ble hypercapnic COPD, comparing BPPV plus VT targeting
(AVAPS) vs. pressure support (PS) in a spontaneous mode
(S): PaCO2 improved slightly more with BPPV and VT target-
ing although comfort was lower with VT targeting than with
PS.18 The second was a trial of 10 OHS patients with OSAS
who did not respond to CPAP therapy: Storre et al. ran-
domly assigned patients to receive bi-level pressure venti-
lation (BPPV) for 6 weeks, with or without VT targeting
(AVAPS), in a cross-over design, and assessed efficacy of
ventilation, quality of sleep and health-related quality of
life (HRQL).5 BPPV with and without VT targeting both
increased slow wave sleep and improved results of a dis-
ease-specific HRQL score. However, BPPV with VT targeting
resulted in a more efficient decrease in TcPCO2 than BPPV
alone.
The concept of VT targeting is interesting especially in
patients with severe OHS, because of the low compliance
of their respiratory system, and the difficulty in controlling
nocturnal hypoventilation in these patients.5 Indeed, Storre
et al. documented, in 10 patients with OHS, incomplete
correction of nocturnal hypoventilation (TcPCO2) with
BPPV alone. We recently studied 20 patients on long-term
BPPV for OHS: 30% had a mean nocturnal TcPCO2
>45 mm Hg.11 Although volumetric ventilation is an option
in these patients, it is more cumbersome, more expensive,
can be poorly tolerated,19 and is thus rarely used.2,20 Both
our study and that of Storre et al. suggest improved correc-
tion of nocturnal TcPCO2 with BPPV when using VT
targeting.
There is, however, a paradox in implementing VT target-
ing. BPPV settings for IPAP are usually close to maximal
values tolerated, and IPAP values above 22 cm H2O are sel-
dom used in this indication on a long-term basis.2,5,20 In
a multicentric study of NPPV, average IPAP values in pa-
tients with OHS were 18 3 cm H2O.2 There is, therefore,
a risk of increased discomfort, suggested by our study and
that of Tramacere et al., which may lead to decreased com-
pliance: this should be specifically studied. Interestingly,
leaks were apparently not increased when using VT target-
ing vs. conventional BPPV.5
Our impression is that the suggested target VT for obese
patients is, at least initially, too high; if implemented in
patients already under BPPV, target VT should be increased
progressively, starting at estimated VT without VT targeting
or at a target VT of 8 ml/kg of ideal body weight.Study limitations
The aim of the study was essentially to detect obvious
alterations of sleep structure induced by changes in
ventilator mode and changes in correction of nocturnal
hypoventilation.
We chose to include patients who were accustomed to
BPPV, compliant to treatment, in order to minimize
alterations in sleep quality which would have been related
to the introduction of BPPV per se, and to focus only on
changes induced by volume targeting. However, because
patients were familiar with BPPV in a conventional mode,
introduction of volume targeting may have been perceived
as less comfortable than in ‘‘naı¨ve’’ patients.
Table 3 Patient’s rating of quality of sleep and comfort of ventilation with and without VT targeting, assessed by St. Mary’s
Hospital Questionnaire and eight visual analogic scales.
St. Mary’s Hospital sleep questionnaire Without VT targeting
mean SD
With VT targeting
mean SD
p Value*
Depth of sleep (scale range: 1e8)a 5.6 1.6 3.3 1.7 0.005
Number of awakenings 3.3 2.0 4.9 2.3 0.01
Duration of sleep (hh:mm) 07:13 02:16 05:33 02:31 0.06
Quality of sleep (scale range: 1e5)a 3.8 0.6 2.8 1.2 0.05
Morning sleepiness (scale range: 1e6)a 4.0 0.7 3.6 1.0 0.13
Satisfaction with quality of sleep (scale range: 1e5)a 3.8 1.1 2.9 1.1 0.08
Early awakening (yes/no) 6/6 6/6
Difficulty in falling asleep (scale range: 1e4) 1.4 1.0 2.1 1.3 0.04
Time needed to fall asleep (hh:mm) 00:46 01:10 00:54 00:55 0.2
Comfort of ventilation (VAS scales, 0e10)
Comfort of ventilationa 7.5 1.9 6.0 2.5 0.018
Desychronisation perceived by patienta 7.5 2.2 6.1 3.1 0.2
Too much air delivereda 9.0 1.9 6.0 3.8 0.012
Too little air delivereda 7.7 2.9 8.0 2.8 1.00
Morning headachea 9.7 0.9 9.7 0.7 1.00
Perception of leaksa 7.7 2.4 4.8 3.7 0.016
Noise of ventilatora 7.5 2.2 6.5 2.8 0.44
Quality of sleepa 6.8 2.6 4.8 2.7 0.02
Items: ‘‘Number of awakenings’’, ‘‘Duration of sleep’’ and ‘‘Time needed to fall asleep’’ are patients’ estimation. (*): p Value for
Wilcoxon’s signed rank test.
a Higher values indicate better quality of sleep or treatment comfort.
Impact of average volume-assured pressure support on non-invasive ventilation 171Because PSG recordings were performed in routine
conditions, without a pneumotachograph (other than that
built-in the ventilator), we did not report in detail
respiratory events occurring under BPPV, such as central
or obstructive apnea or hypopnea, or patient-ventilator
asynchrony. Indeed, there is to date no consensus for the
description and quantification of these respiratory events
under NPPV. The ODI was not significantly altered when
introducing VT targeting in the present study suggesting
that there was no significant effect of VT targeting on respi-
ratory events occurring under BPPV.5
Also, because we did not add a pneumotachograph to
the ventilation circuit, there was no quantification of leaks:
furthermore, the ventilatoresoftware combination studied
did not allow estimation of leaks, although this is possible
with the more recent Synchrony ventilators and updated
software (Respironics Inc., Murrysville, PA). The major
consequences of leaks are disrupted sleep structure,6 desa-
turations, and patient-ventilator asynchrony. Leaks were
not significantly different with and without VT targeting in
the study by Storre et al.5
Conclusion
VT targeting is a potentially useful parameter to improve
efficacy of bi-level positive pressure ventilation. In this
study, we confirmed that VT targeting improves correction
of nocturnal hypoventilation in stable patients with OHS
treated by NPPV, at the expense of minor alterations of
sleep structure and fragmentation, and of a slight decrease
in patient comfort. Further studies should explore thecontribution of VT targeting in other indications (i.e., acute
hypercapnic failure in obese subjects, neuro-muscular dis-
orders or COPD), as well as its impact on objective mea-
surements of compliance. Indeed, patient’s perception of
increased discomfort may compromise long-term compli-
ance to NPPV. Conversely, progressively increasing target
VT, and lower target VT values may improve tolerance
and patient comfort. Increased clinical experience is nec-
essary to determine optimal ventilator settings with VT
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